ArticleFrontiers in cardiovascular medicine2026
Ultrasound-guided stellate ganglion block for refractory sympathetically mediated arrhythmia following acute myocardial infarction: a tutorial and examples.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sympathetic arrhythmia represents a life-threatening complication following acute myocardial infarction (AMI), which is characterized by recurrent episodes of electrical dysrhythmias that are often refractory to antiarrhythmic medications and thereby necessitate repeated electrical cardioversion or defibrillation. This case series aims to evaluate the efficacy and safety of ultrasound-guided stellate ganglion block (SGB) as a rescue therapy for refractory ventricular arrhythmias and one case of rapid atrial flutter following AMI. Methods: We retrospectively analyzed five AMI patients with refractory sympathetically arrhythmia who failed standard medical management. All patients were of Han ethnicity from China, consisting of three males and two females, with ages ranging from 29 to 87 years. All patients underwent bedside ultrasound-guided SGB (unilateral or bilateral) with 1% lidocaine hydrochloride. The primary outcomes were immediate termination of sympathetically arrhythmia and 24-hour arrhythmia-free survival. Results: SGB successfully aborted electrical storm in all 5 patients (100%). The median number of defibrillations per patient decreased significantly from 4 [interquartile range (IQR): 2.5-21] before SGB to 0 (IQR: 0-1) after SGB. The development of ipsilateral Horner syndrome in all cases confirmed successful sympathetic blockade, and no procedure-related complications were observed. Discussion: SGB is a safe and effective bedside intervention for terminating and stabilizing refractory sympathetically arrhythmia in post-AMI patients. It can serve as an important adjunctive therapy to reduce the need for repeated electrical defibrillation. Further prospective randomized controlled studies are warranted to validate its clinical application in acute arrhythmia management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.